Infertility Drugs Market Growth Accelerated by Increased Awareness for Infertility Treatment Options

Infertility drugs refer to medications that help induce ovulation and increase fertility in women with ovulation disorders. These drugs help induce ovulation and regulate the menstrual cycle. The rising cases of infertility coupled with rising awareness regarding infertility treatment options are major factors propelling the demand for infertility drugs. Infertility is a condition in which a couple is unable to conceive naturally after attempting for 12 months.

The global infertility drugs market is estimated to be valued at US$ 3,699 million in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Key Trends:
The increased awareness regarding infertility treatment options is one of the key trends driving the growth of infertility drugs market. Majority of people today are more aware about infertility as a medical condition. They are also well informed about various treatment options such as IVF and IUI available for treatment of infertility. This rising awareness has increased the demand for infertility drugs which help improve fertility. For example, awareness campaigns by healthcare organisations and fertility clinics help people understand fertility issues and available treatment options. This plays a vital role in boosting the demand for various infertility drugs used in IVF and other assisted reproductive techniques.

Segment Analysis
The global infertility drugs market is segmented on the basis of product, therapy, end user and distribution channel. Based on product, it is segmented into fertility drugs for women and fertility drugs for men. Among these, fertility drugs for women dominated the market in 2021 owing to increase in awareness about fertility issues and treatment options available for women. Based on therapy, it is segmented into ovulation stimulation, follicle stimulating hormone therapy, clomiphene citrate, human chorionic gonadotropin (hCG), and others. Among these, follicle stimulating hormone therapy dominated the market in 2021 due to its efficacy in treating fertility related disorders in both men and women.

Key Takeaways
The Global Infertility Drugs Market Size is expected to witness high growth over the forecast period of 2023-2030. The market size is projected to grow from US$ 3699 million in 2023 to US$ 6307 million by 2030, registering a CAGR of 5.9%.

Regional analysis: North America currently dominates the global infertility drugs market, owing to the presence of advanced healthcare facilities, rising infertility rates, favourable reimbursement policies, and high patient awareness in the region. However, the Asia Pacific region is expected to be the fastest growing market during the forecast period due to the increasing women workforce, rising medical tourism, escalating disposable incomes, and growing public awareness.

Key players: Key players operating in the infertility drugs market are Merck, Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., Abbott, Bayer AG, Zydus Pharmaceuticals, Ltd., and Sun Pharmaceutical Industries Ltd. Major players are focusing on new product launches, regional expansion and mergers & acquisitions to strengthen their market position.

Get more insights on this topic:
https://www.marketwebjournal.com/infertility-drugs-market-trends/

Explore more trending article:
https://www.marketwebjournal.com/office-furniture-market-share/